Skip to Content

MYLAN 152 (Clonidine 0.1 mg)

Pill imprint MYLAN 152 has been identified as Clonidine hydrochloride 0.1 mg.

Clonidine is used in the treatment of opiate withdrawal; adhd; anxiety; benzodiazepine withdrawal; restless legs syndrome (and more), and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Clonidine 0.1 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Clonidine hydrochloride 0.1 mg MYLAN 152
Clonidine hydrochloride 0.1 mg MYLAN 152
Clonidine hydrochloride 0.1 mg MYLAN 152
Clonidine hydrochloride
0.1 mg
6.00 mm
Prescription only
Drug Class:
Antiadrenergic agents, centrally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
Inactive Ingredients:
ammonium chloride
silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
sodium lauryl sulfate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0299 UDL Laboratories Inc
54569-0478 A-S Medication Solutions, LLC (repackager)
00615-2572 Vangard Labs Inc (repackager)
68115-0087 Dispensexpress Inc (repackager)
54868-0048 Physicians Total Care Inc (repackager)
49999-0127 Lake Erie Medical and Surgical Supply (repackager)
63874-0475 Altura Pharmaceuticals Inc (repackager)
23490-5351 Palmetto State Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.